2017/2710(DEA)

Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections

Basic information

2017/2710(DEA)

DEA - Delegated acts procedure

Supplementing 2012/0192(COD)

Subject

4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

Key players

  • European Parliament
    Committee responsible Rapporteur Appointed
    ENVI
    Environment, Climate and Food Safety

Key events

Date Event Reference Summary
23/05/2017 Non-legislative basic document published C(2017)03368
23/05/2017 Initial period for examining delegated act 2.0 month(s)
31/05/2017 Committee referral announced in Parliament
17/07/2017 Delegated act not objected by Council
01/08/2017 Delegated act not objected by Parliament

Technical information

Procedure reference 2017/2710(DEA)
Procedure type DEA - Delegated acts procedure
Procedure subtype Examination of delegated act
Supplementing 2012/0192(COD)
Stage reached in procedure Procedure completed - delegated act enters into force
Committee dossier ENVI/8/10003

Documentation gateway

  • Document type Reference Date Summary
    Non-legislative basic document C(2017)03368 23/05/2017
    Document attached to the procedure C(2019)6491 06/09/2019